Helping Your Lab Stay Afloat During Challenging Times Subscribe Now! COVID-19 Business Intelligence and Analysis for Clinical Laboratories, Pathology Groups and Hospital Administration Free COVID-19 Webinar! Sponsored by Register Now Start and Scale COVID-19 Testing with Essential Tools that Support
the Business and Workflow of Your Lab
Weds., July 22 @ 1PM EDT
NEW WHITE PAPER! Translating Clinical Laboratory Science Into Business Objectives:
How an Educational Program Measured and Analyzed Performance
and Transformed the Approach to Improving Laboratory Operations
FREE DOWNLOAD! White Paper - Translating Clinical Lab Science into Business Objectives
Try The Dark Report for 14 days, absolutely FREE Lab leaders rely on The Dark Report for actionable intelligence on key developments
in the laboratory testing industry, including compensation trends and market
milestones. It’s the single-best source of the information you need to maximize
the money you make, and the money you keep!
Start Your FREE Trial BONUS Special Report, Intelligence Assessment of Today’s
Clinical Laboratory Industry
, when you order today!
WHITE PAPER FREE SPECIAL EDITION WHITE PAPER
Molecular Testing for Urinary Tract Infection (UTI):
2020 Update on Clinical Utility and Reimbursement Trends
FREE DOWNLOAD
3 High-Risk Medical Courier Support Services Risk Management
Specimen Management and Logistics Issues to Evaluate for Continuous
Quality Improvement
FREE DOWNLOAD NEW WHITE PAPER!

Latest White Papers

Molecular Testing for Urinary Tract Infection (UTI): 2020 Update on Clinical Utility and Reimbursement Trends

Molecular tests are becoming more routine as diagnostic tools, with many now covered by Medicare and commercial insurers. Advantages of molecular tests based on PCR technology include their ability to identify uropathogens traditionally missed by culture-based tests.

Driven by urgent, unmet analytical and clinical care needs, the adoption of the rapid molecular test—particularly RT-PCR for urinary tract infection control and treatment—has important implications.

read more
Case Studies in Clinical Laboratory Test Stewardship: The Financial and Clinical Impact of Clinical Decision Support in Hospital Laboratories

This white paper – the third in a three-part series developed in collaboration with Mayo Clinic Laboratories and Change Healthcare – provides frontline perspective and commentary from experts and physicians on the application and value of decision support in the laboratory. It also includes early-adopter proof points from hospital laboratories that have successfully implemented third-party decision support to achieve their stewardship goals, including EHR interventions and ongoing monitoring of utilization.

read more
Translating Clinical Laboratory Science Into Business Objectives: How an Educational Program Measured and Analyzed Performance and Transformed the Approach to Improving Laboratory Operations

Now more than ever before, clinical labs are under pressure to operate efficiently, accurately, and timely, all while still making money. Doctors and patients have come to expect a 24-hour turnaround for most tests. Clinical labs throughout the United States have been slashing budgets, many literally to the point of no return. At least 13 public health labs in four states have shuttered since 2003, which posed a serious problem when COVID-19 hit because resources did not meet demand.

read more
Critical Factors for Launching a Clinical Decision Support System in the Hospital Laboratory

This white paper—part 2 of a three-part series— provides practical pearls on how a proven decision support solution and one that is a good fit for your lab can be the foundation of an effective laboratory stewardship program, and can greatly assist in controlling utilization and meeting the challenges of value-based care. As well, the paper also clearly explains the points for “buy versus build” laboratory decision support.

Choosing the right decision support solution will empower your lab and hospital leaders, clinicians, and staff with more time to focus their core competencies on the provision of healthcare. Learn what you need to know by downloading this FREE whitepaper now.

read more
Anatomic Pathology at the Tipping Point? The Economic Case for Adopting Digital Technology and AI Applications Now

Driven by recent technological and regulatory approvals, leading academic and commercial laboratories are increasingly going digital to overcome significant gaps in efficiency and diagnostic accuracy. These same labs are implementing computational applications that leverage artificial intelligence (AI) to expand on the productivity, quality, and confidence gains they’ve already realized.

Download the White Paper now to get a synopsis of recent research and real-world cases that demonstrate the economic and scientific necessity of adopting digital pathology platforms and AI applications. Gather perspective from in-depth interviews with industry-leading labs that lay out the benefits they themselves gained from going digital.

read more

Latest E-Briefings

Federal Prosecutors Add a 12th Felony Fraud Charge in Latest Criminal Indictment Against Theranos Founder Elizabeth Holmes

Holmes’ lawyers maintain the former CEO of Theranos has not waived right to be charged by indictment and therefore argue the added charge is ‘unconstitutional’ and should be dismissed Clinical laboratory leaders needing a break from nonstop coronavirus pandemic news...

read more

Two Florida Clinical Laboratory COVID-19 Test Contracts Come Under Scrutiny

One medical testing company was led by a convicted felon, another was accused of delays and unreliable results Like many states, Florida has worked hard to quickly ramp up diagnostic testing for SARS-CoV-2, the coronavirus that causes the COVID-19 illness. For the...

read more

New Gene Sequencing Method for Studying Circular DNA Found in Viruses, Bacteria, and other Cells, May Lead to Development of New Clinical Laboratory Biomarkers

University of Alberta researchers developed CIDER-Seq tool and protocols for the study, which they have made freely available to all scientists Here’s another promising new technology which, given more research into effectiveness and safety, may soon lead to improved...

read more

Australia Spent $200 Million (AUD) on Chinese COVID-19 Diagnostic Testing Kits That Went into The Country’s Strategic Reserve Rather than Being Used

Australian government heralded April purchase of 10 million clinical laboratory diagnostics tests from BGI, but most of the nation’s states and territories say kits are unneeded or unable to be used by their health departments While the United States and other nations...

read more

Multiple Studies Raise Questions About Reliability of Clinical Laboratory COVID-19 Diagnostic Tests

In the absence of a “gold standard,” researchers are finding a high frequency of false negatives among SARS-CoV-2 RT-PCR tests Serology tests designed to detect antibodies to the SARS-CoV-2 coronavirus that causes the COVID-19 illness have been dogged by...

read more

FTC Orders Hospital, Health System, and Five Insurers in Two States to Share Vast Amounts of Data on Their Customers and on Past Acquisitions and Mergers

Lab leaders may recall similar requests for data from other government agencies and wonder if FTC will take steps to investigate pricing and competition among clinical laboratories as well It appears that the Federal Trade Commission (FTC) is ready to look into...

read more

Molecular Testing for Urinary Tract Infection (UTI): 2020 Update on Clinical Utility and Reimbursement Trends

Molecular tests are becoming more routine as diagnostic tools, with many now covered by Medicare and commercial insurers. Advantages of molecular tests based on PCR technology include their ability to identify uropathogens traditionally missed by culture-based tests.

Driven by urgent, unmet analytical and clinical care needs, the adoption of the rapid molecular test—particularly RT-PCR for urinary tract infection control and treatment—has important implications.

read more

Medical Laboratory Test Data and Clinical Lab 2.0 are Powering Dashboards That Help Providers Mitigate COVID-19 and Improve Population Health

Coronavirus informatics companies are drawing clinical laboratory test data out of the shadows and into the light and compiling it into critical bioinformatics resources What better example do we have that clinical laboratory test data is critical to population health...

read more

Case Studies in Clinical Laboratory Test Stewardship: The Financial and Clinical Impact of Clinical Decision Support in Hospital Laboratories

This white paper – the third in a three-part series developed in collaboration with Mayo Clinic Laboratories and Change Healthcare – provides frontline perspective and commentary from experts and physicians on the application and value of decision support in the laboratory. It also includes early-adopter proof points from hospital laboratories that have successfully implemented third-party decision support to achieve their stewardship goals, including EHR interventions and ongoing monitoring of utilization.

read more

Translating Clinical Laboratory Science Into Business Objectives: How an Educational Program Measured and Analyzed Performance and Transformed the Approach to Improving Laboratory Operations

Now more than ever before, clinical labs are under pressure to operate efficiently, accurately, and timely, all while still making money. Doctors and patients have come to expect a 24-hour turnaround for most tests. Clinical labs throughout the United States have been slashing budgets, many literally to the point of no return. At least 13 public health labs in four states have shuttered since 2003, which posed a serious problem when COVID-19 hit because resources did not meet demand.

read more

Latest Webinars

green FEATURED SPEAKERS Nicole M. Green, PhD Director, Public Health Laboratory
Los Angeles County
Department of Public Health
wesgard Sr. FEATURED SPEAKERS James O. Westgard, PhD Founder, Principal Madison, WI James O. Westgard, PhD, FACB Westgard QC, Inc.